Salatan, Janese A.

HRN: 23-13-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2023
CEFUROXIME 1.5GM (VIAL)
06/28/2023
07/05/2023
IV
1.5 Grams
Q8
SP LT CS W IUD Insertion
Waiting Final Action 
06/29/2023
CEFUROXIME 500MG (TAB)
06/29/2023
07/05/2023
PO
500mg
BID
S/P LSCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: